THE PSYCHIATRIC SIDE-EFFECTS OF IPRONIAZID
The DOI matches its Crossref record.
Abstract
Iproniazid is a powerful stimulant which can be very useful in the treatment of debilitated individuals. Its use is limited because of the severity and frequency of side-effects. The psychiatric complications are more frequent than the systemic or neurological toxic reactions. Poor psychiatric risks should not be treated with Iproniazid; all patients receiving the drug should be under constant psychiatric observation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Antidepressant-induced mania and cycle acceleration: a controversy revisited
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.8.1130 · Cited by 608
Can antidepressants cause mania and worsen the course of affective illness?
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.11.1403 · Cited by 398
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.2.179 · Cited by 357
Monoamine oxidase and cigarette smoking
Fowler, J. S., Logan, J., Wang, G.-J., & Volkow, N. D. (2003) · NeuroToxicology · doi:10.1016/s0161-813x(02)00109-2 · Cited by 251
“Medical interest in MAO was stimulated in the early 1950s when it was discovered that iproniazide, a drug which was being used to treat tuberculosis, elevated mood in some patients (Selikoff et al., 1952; Crane, 1956).”
Background
Metadata
- Authors
- CRANE, G. E.
- Venue
- American Journal of Psychiatry
- Published
- 1956-01
- Volume
- 112
- Issue
- 7
- Pages
- 494-501
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2073609038
- Cited by
- 99
- References
- 0
- FWCI
- 13.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: THE PSYCHIATRIC SIDE-EFFECTS OF IPRONIAZID. https://app.cochat.ai/papers/10.1176/ajp.112.7.494
- The paper
- CRANE, G. E. (1956). THE PSYCHIATRIC SIDE-EFFECTS OF IPRONIAZID. American Journal of Psychiatry. https://doi.org/10.1176/ajp.112.7.494
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.